Result of Buy-Back and total voting rights

RNS Number : 0723B
Honeycomb Investment Trust PLC
27 January 2020
 

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (OTHER THAN THE UNITED KINGDOM), CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

27 January 2020

Honeycomb Investment Trust plc
(the "Company")
Result of Buy-Back and total voting rights

Honeycomb Investment Trust plc announces that it has repurchased into treasury 2,200,000 Ordinary Shares at a price of 850 pence per Ordinary Share.

Further to the announcement earlier today regarding the irrevocable undertaking entered into by a major shareholder (the "Major Shareholder") (the "Irrevocable"), the Company and the Investment Manager authorised a sale of Ordinary Shares by the Major Shareholder and the Irrevocable now survives over the Major Shareholder's remaining holding of 6,043,595 Ordinary Shares.

Total voting rights

Following completion of the Buyback, the Company has 39,449,919 Ordinary Shares in issue, of which 2,200,000 Ordinary Shares are held in treasury. The total number of voting rights in the Company is therefore 37,249,919 Ordinary Shares.

Capitalised terms used in this announcement shall have the same meanings as those defined in the announcement released earlier today.

Liberum Capital Limited - Broker

Chris Clarke / Louis Davies: +44 (0)20 3100 2000

Camarco - Investor Relations

Ed Gascoigne-Pees: +44 (0)20 3757 4994

Link Company Matters Limited - Corporate Secretary

Paula O'Reilly: +44 (0)20 7954 9796

Pollen Street Capital - Investment Manager

Chris Palmer / Steve Plowman: +44 (0)20 3728 6750

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUBUWRRSUAUAR
UK 100